Digital Health
The investment comes less than a year after the company launched with $9 million in funding, bringing its total raise to more than $25 million.
The publicly traded company, which announced it was seeking strategic alternatives for its business last month, will go private thanks to the merger.
HIMSS24
Dr. Michal Tzuchman Katz, cofounder and CEO of Kahun, discusses how educating doctors on the source of information for the company's clinical knowledge graph and how the product supports patient care encourage its adoption.
A study published in Clinical Imaging says ChatGPT can simplify radiology reports, but the results differ significantly based on racial context.
Ansys industry director for Healthcare Solutions Thierry Marchal and researcher María Angeles Pérez discuss how combining clinical data and mathematical models can increase precision and expedite treatment plans.
The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials.
Patients of the medical center's hospital-at-home program in Minnesota and Florida will be able to receive home deliveries via Zipline's drones.
HIMSS24
Dr. Tim O'Connell, cofounder and CEO of Emtelligent, believes healthcare organizations should not rely solely on AI for business processes and must train models on data sets that represent "all of humanity."
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.